Cargando…
Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
PURPOSE: Tranexamic acid (TXA) is a widely used antifibrinolytic agent that can also cause a decrease in vascular permeability. We hypothesized that TXA could improve macular edema (ME) that is caused by an increase in retinal vascular permeability. The aim of this study is to evaluate the efficacy...
Autores principales: | Takeyama, Masayuki, Takeuchi, Fumio, Gosho, Masahiko, Sugita, Keijiro, Zako, Masahiro, Iwaki, Masayoshi, Kamei, Motohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745154/ https://www.ncbi.nlm.nih.gov/pubmed/29339919 http://dx.doi.org/10.2147/OPTH.S149935 |
Ejemplares similares
-
Intravitreal Injection of Bevacizumab to Treat a Macular Edema Caused by Leber's Miliary Aneurysm
por: Takeyama, Masayuki, et al.
Publicado: (2012) -
Decreased VEGF-A and sustained PEDF expression in a human retinal pigment epithelium cell line cultured under hypothermia
por: Takeyama, Masayuki, et al.
Publicado: (2015) -
Ocular parameters before and after steep Trendelenburg positioning for robotic-assisted laparoscopic radical prostatectomy
por: Mizumoto, Kyoichi, et al.
Publicado: (2017) -
Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2019) -
Recurrent vitreous hemorrhage associated with regressed retinopathy of prematurity in a 47-year-old patient: a case report
por: Takeyama, Masayuki, et al.
Publicado: (2014)